NextVein LLC — SEC Form D Filing

NextVein LLC filed an SEC Form D on November 3, 2026, reporting $1.20M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
November 3, 2026
Amount reported
$1.20M
Round stage
Seed
Industry
Medical Devices
Website
https://nextvein.com/

What the company does

Exemption: Rule 506(b). Incorporated: NEW YORK

Problem

Clinicians often struggle to quickly and accurately locate veins for IV access, blood draws, and cosmetic procedures, leading to missed sticks, increased patient pain, and clinical escalations, while existing visualization devices are often cost-prohibitive.

Solution

NextVein develops the V800NV, an affordable handheld near-infrared vein finder that projects a real-time image of vasculature directly onto the patient's skin and can convert to hands-free use during procedures.

Why now

Hospitals and outpatient clinics are under margin pressure to reduce disposable supply waste and improve patient satisfaction metrics, driving demand for lower-cost alternatives to legacy vein visualizers.

Verdict

Investors backed an arbitrage on price deflation rather than technological novelty. This cleared because incumbent pricing by AccuVein established clinical demand while leaving lower-margin outpatient clinics unaddressed, not because NextVein pioneered a proprietary imaging breakthrough. The implicit bet was that clinical buyers would swap out recognized, expensive brands for a cheaper handheld alternative without requiring enterprise procurement buy-in. Upside is structurally capped by the absence of high-margin disposable attachments and the relentless threat of commoditized overseas manufacturing undercutting the wedge.

Source: SEC EDGAR Form D filing